Stem cell therapy frees diabetics from insulin

A new study shows that a single dose of manufactured stem cells eliminated the need for insulin in ten out of twelve patients with Type 1 diabetes for at least a year. This marks a significant advancement in diabetes treatment. The experimental stem cells, designed to grow in the liver and produce insulin, stopped dangerous low blood sugar episodes in the patients. However, the treatment requires lifelong immune-suppressing drugs, which carry risks. Researchers are continuing the study and exploring ways to eliminate the need for immune suppression. The therapy offers hope for a renewable source of insulin-producing cells, potentially revolutionizing diabetes treatment.